Related Experiment Videos
Studies on C3ahu binding to human eosinophils: characterization of binding
International Archives of Allergy and Applied Immunology
|January 1, 1984
Summary
Human complement component 3a (C3a) preferentially binds to eosinophils, not neutrophils or platelets. This specific binding suggests a potential physiological role for C3a in eosinophil function.
Area of Science:
- Immunology
- Complement System Biology
Background:
- The complement system is a crucial part of innate immunity.
- Complement component 3a (C3a) is a potent anaphylatoxin with known inflammatory roles.
Purpose of the Study:
- To investigate the binding characteristics of purified C3a to human blood cells.
- To determine the specificity and kinetics of C3a binding to eosinophils.
Main Methods:
- Purification of C3a from human serum.
- Incubation of purified C3a with human eosinophils, neutrophils, and platelets.
- Radioligand binding assays using 125I-C3a.
- Kinetic analysis of C3a binding and dissociation.
Main Results:
- Purified C3a demonstrated preferential binding to human eosinophils over neutrophils.
- Minimal to no C3a binding was observed with human platelets.
- Maximum C3a binding to eosinophils occurred within 15 minutes at 37°C.
- The dissociation half-life (T1/2) of C3a from eosinophils was approximately 30 minutes.
- A C3a degradation product, C3adesArg, did not bind to eosinophils and did not inhibit C3a binding.
Conclusions:
- C3a exhibits specific binding to human eosinophils.
- The binding kinetics suggest a potentially significant interaction.
- These findings support a possible physiological role for C3a in modulating eosinophil motility or other functions.